Pi Pharma Covid-rapid Antigen Test (2020-12-18)

API PHARMA COVID-RAPID ANTIGEN TEST RECALL API Pharma's COVID-Rapid Antigen Test is being recalled across Canada due to issues with the medical device. This is a Class I recall, which means the product could cause serious harm or death. The recall affects COVID-19 rapid antigen tests distributed throughout Canada.

Reason
COVID - Medical devices
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DEVICES
Recall date
2020-12-31
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DEVICES

Recall details on Nibble Recalls: https://trynibble.app/recalls/2a179e8b-5ae4-42a4-b237-1a1839d1f56f